￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
BRIGHTSTAR Final Analysis evaluates the efficacy of local consolidation therapy brigatinib in patients with TKI-naïve, ALK-rearranged non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Entrectinib is produced by which company?

2026-02-01 22:25:32

Check Details
Acotinib/venetoclax sNDA under FDA review for previously untreated CLL

2026-02-01 22:25:32

Check Details
Which pharmaceutical company produces ibrutinib/ibrutinib?

2026-02-01 22:25:32

Check Details
Safety of Imetelstat plus ruxolitinib tablets/Jiekewei in the treatment of high-risk myelofibrosis

2026-02-01 22:25:32

Check Details
The effect of clofazimine/sempra soft capsules in treating tuberculosis

2026-02-01 22:25:32

Check Details
Enasidenib official purchase method and usage method

2026-02-01 22:25:32

Check Details
How much does one month of amivantamab treatment cost?

2026-02-01 22:25:32

Check Details
What is the Difference Between Enzalutamide (Enzalutamide) and Enzalutamide

2026-02-01 22:25:32

Check Details
What are the efficacy and side effects of pemetinib/pemetinib?

2026-02-01 22:25:32

Check Details
Has Erdafitinib been included in medical insurance reimbursement?

2026-02-01 22:25:32

Check Details
Is dacomitinib/dacomitinib a domestic drug or an imported drug?

2026-02-01 22:25:32

Check Details
Category
相关知识